Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3

Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value

$122.94+0.23 (+0.19%)

Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –

Haemonetics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Haemonetics's EV/EBITDA was 22.2× on Nov 11, 2026, against 13.3× a year earlier. Over the last 5 years it ranged from 9.3× to 27.9×, with a median of 18.7×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	22.2×	+9.1
2025	Dec 31, 2025	13.1×	−4.5
2024	Dec 31, 2024	17.6×	−0.7
2023	Dec 29, 2023	18.2×	−1.8
2022	Dec 30, 2022	20.0×	−4.1
2021	Dec 31, 2021	24.2×	−2.3
2020	Dec 31, 2020	26.4×	−3.8
2019	Dec 31, 2019	30.2×	−6.7
2018	Dec 31, 2018	37.0×	+3.2
2017	Dec 29, 2017	33.8×	−23.7
2016	Dec 30, 2016	57.5×	+43.7
2015	Dec 31, 2015	13.8×	−3.8
2014	Dec 31, 2014	17.7×	−2.1
2013	Dec 31, 2013	19.8×	+0.3
2012	Dec 31, 2012	19.5×	+10.3
2011	Dec 30, 2011	9.1×	−2.1
2010	Dec 31, 2010	11.2×	+0.7
2009	Dec 31, 2009	10.5×	–